Welcome to the Virtual MS Center!
Ask any question you want about Multiple Sclerosis and one of our experts will answer it as soon as possible.
Question: We know that Tysabri is very effective in reducing relapse frequency and appearing of new lesions, but how effective is it in preventing progression? Or conversion from RRMS to SPMS?
Answer: Several small studies suggest a benefit of Tysabri for secondary progressive MS. A large definitive clinical trial called ASCEND, funded by Biogen Idec, is underway with expected completion by the end of 2014.
Mary
1/21/2014 12:18:58 pm
What i meant is (for the first part of the question), does Tysabri slow progression in RRMS patients, along with reducing new lesions and relapses? What do clinical trials say on that one?
Dr Kinkel
1/22/2014 03:30:50 am
Tysabri has remarkable benefits in Relapsing forms of MS. These include the following effects over 2 years compared to placebo treated patients: Comments are closed.
|
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.
Archives
February 2021
Categories
All
|